May 7, 2018
LIPIMETIX DEVELOPMENT ANNOUNCES SUB-LICENSE OF APO E MIMETIC PEPTIDE PLATFORM TO ANJI PHARMA, CHINA
>> Read More
November 14, 2017
eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American Heart Association
>> Read More
December 19, 2016
Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study
>> Read More
Aug. 25, 2016
Capstone Therapeutics Announces That Its Joint Venture, LipimetiX Development, Inc.
>> Read More
Feb. 03, 2016
Capstone Therapeutics Announces Existing Shareholder Decision Not to Extend Exclusive due Diligence Period Other OTC_CAPS
>> Read More
Dec. 15, 2015
Capstone Therapeutics Announces Loan From Existing Shareholder for Exclusive Due Diligence Period Other OTC_CAPS
>> Read More
Oct. 14, 2015
Capstone Therapeutics Announces Allowance of U.S Patent for Treatment of Diabetes with Apo E Mimetic Peptides
>> Read More